SGLT2-inhibitors: No Benefit in Hospitalized COVID-19 ...Middle East

Medscape - News
However, an important take-home message from this new meta-analysis is that these widely used medications appeared to be safe even in acutely ill hospitalized patients, the researchers say. Medscape Medical News

Hence then, the article about sglt2 inhibitors no benefit in hospitalized covid 19 was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SGLT2-inhibitors: No Benefit in Hospitalized COVID-19 )

Apple Storegoogle play

Last updated :

Also on site :



Latest News